| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 230,484 | 262,705 | 267,723 | 315,561 | | Cost of Revenue | 168,676 | 211,622 | 204,933 | 241,838 | | | Gross Profit | 61,808 | 51,083 | 62,790 | 73,723 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 42,564 | 54,372 | 49,954 | 54,212 | | Non Recurring | 1,779 | 63 | 52,567 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 17,465 | (3,352) | (39,731) | 19,511 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 13,427 | (3,352) | (39,731) | 19,511 | | Interest Expense |
-
| (3,083) | 1,072 | 6,284 | | Income Before Tax | 13,427 | (269) | (40,803) | 13,227 | | Income Tax Expense | 5,337 | (1,534) | 347 | 5,087 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 7,094 | 1,265 | (41,150) | 8,140 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 8,090 | 1,265 | (41,150) | 8,140 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $8,090 | $1,265 | ($41,150) | $8,140 |
|
0.08% Nasdaq 
Income Statement
